Sigma-Aldrich
Life Science

Antibodies
Automation
Cancer Research
Cell Culture
Cell Signaling and Neuroscience
Custom Synthesis
Drug Discovery
Epigenetics
Functional Genomics and RNAi
Metabolomics
Molecular Biology
Neuroscience
Nutrition Research
Obesity Research
Key Resources
Biogenic Amines
Effects of Cytokines
Effects of Peptides
Lipid Metabolism
Product Lines
Peptides and Proteins
Plant Biotechnology
Proteomics and Protein Expr.
Stable Isotopes
Stem Cell Biology
Your Favorite Gene - Search
Life Science Innovations
PathFinder

 Effects of Cytokines on Food Intake and Obesity

Obesity Research
 

A relationship exists between cytokines and both leptin (L4146) and insulin ( I1507). Proinflammatory cytokines increase leptin levels while leptin regulates pro- and anti-inflammatory cytokine production. Interleukin-1 (IL-1) is a proinflammatory cytokine that promotes the release of corticotrophin releasing factor (CRF) (C3042), which suppresses feeding behavior. Excess IL-1 signaling induced by leptin suppresses feeding behavior via melanocortin receptors (H2396) [1]. In addition, IL-1 appears to modulate lipid metabolism by suppressing lipoprotein lipase (LPL) (L2254), the enzyme regulating the disposal of lipid stores in the body [1]. Interleukin-6 (IL-6) (I3268) is another proinflammatory cytokine secreted from adipocytes whose circulating levels are elevated in obese individuals. IL-6 is associated with the insulin resistance of obesity and type 2 diabetes [2]. Tumor necrosis factor-α (TNF-α) (T6674) is another proinflammatory cytokine secreted from adipocytes whose overproduction may be the factor that negatively influences the ability of insulin to stimulate glucose transport in adipocytes [3]. Ciliary neurotrophic factor (CNTF) (C3710), a tropic factor first identified in the ciliary ganglion, appears to act similarly to leptin. In leptin-deficient ob/ob mice, CNTF administration has been shown to reduce adiposity, hyperphagia and hyperinsulinemia, similar to leptin [4]. Systemic administration of CNTF activates the JAK/STAT pathway in the ARC, overlapping with those pathways activated by leptin [5]. Unfortunately, Axokine, a modified version of CNTF, showed disappointing results in Phase III trials for the treatment of obesity.

References:

  1. Matsuki, T., et al., IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J. Exp. Med., 198, 877-888 (2003).

  2. Klover, P.J., et al., Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes, 52, 2784-2789 (2003).

  3. Lafontan, M. and Berlan, M., Do regional differences in adipocyte biology provide new pathophysiological insights? Trends Pharmacol. Sci., 24, 276-283 (2003).

  4. Zvonic, S., et al., The regulation and activation of ciliary neurotrophic factor signaling proteins in adipocytes. J. Biol. Chem., 278, 2228-2235 (2003).

  5. Flier, J.S., Obesity Wars: Molecular progress confronts an expanding epidemic. Cell, 116, 337-350 (2004).


back to top
back to Obesity
back to Cytokines, Growth Factors and Hormones